Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05412069 · ClinicalTrials.gov registry record · NA
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
A NA study of Fecal Incontinence and Normal Subjects, sponsored by The California Medical Innovations Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 155
- Enrollment target
- 2
- Study locations
NCT05412069 is a NA study of Fecal Incontinence and Normal Subjects that is actively recruiting participants, run by The California Medical Innovations Institute. The registered enrollment target is 155 participants, below the 328-participant average among 22 other Fecal Incontinence trials with a reported enrollment target (53% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05412069, a NA study of Fecal Incontinence and Normal Subjects, is actively recruiting participants, sponsored by The California Medical Innovations Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 155 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objective is to determine the length-tension properties of the anal sphincters using Fecobionics in normal subjects and FI patients during anal distension and during simulated evacuation. Fecobionics has the consistency and shape of normal stool and can record pressures, cross-sectional area, orientation and viscoelastic properties of the anorectum and can map the geometric profiles during evacuation, and thereby provides multi-dimensional measurements of pressures, deformability, and topographic changes. Fecobionics combines several existing tests to provide novel insight into anorectal function. The purpose for the development was to overcome the technological controversies and disagreement between various tests and unphysiological test conditions. The aim was to imitate defecation as much as possible to the natural process. Fecobionics was developed to simulate stool and to provide the driving pressure and resulting deformations of stool along with a measure of an objective anorectal angle during defecation in a single examination. Fecobionics makes it possible to describe objectively, without disturbing the defecation process, the opening characteristics and pressure signatures during initial entry into the relaxing anal canal. The overall goal is to provide mechanistic understanding of defecation in health and defecatory disorders. It exceeds previous attempts to make artificial stool for evaluation of defecation (BET and FECOM) and integrates other technologies as well. It was designed to have a consistency and deformability of Type 4 (range type 3-5) on the Bristol stool form scale. The range from types 3-5 is found in 70% of normal subjects. A major novelty is that Fecobionics measures pressures in axial direction; i.e., in the flow direction.
Conditions Studied
Interventions
- DEVICE Fecobionics
Study Locations (2)
California
- California Medical Innovations Institute - San Diego
Georgia
- Augusta University Medical Center - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2023-02-15 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05412069
The ClinicalTrials.gov registry entry for NCT05412069 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 155 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 22 other Fecal Incontinence trials with a reported enrollment target (53% lower). The listed sponsor is The California Medical Innovations Institute, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Fecal Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Fecobionics is the first listed.
NCT05412069 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Georgia.
Frequently Asked Questions
What is clinical trial NCT05412069 about?
NCT05412069 is a clinical study titled "Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)". The objective is to determine the length-tension properties of the anal sphincters using Fecobionics in normal subjects and FI patients during anal distension and during simulated evacuation. Fecobionics has the consistency and shape of normal stool and can record pressures, cross-sectional area, or...
What is the current status of trial NCT05412069?
This trial is currently recruiting. It is a NA study. The enrollment target is 155 participants. The study started on 2023-02-15. Estimated completion is 2027-03-31.
What conditions does trial NCT05412069 study?
This clinical trial studies the following conditions: Fecal Incontinence, Normal Subjects.
What interventions are being tested in trial NCT05412069?
The interventions under investigation include: Fecobionics (DEVICE).
Who is sponsoring clinical trial NCT05412069?
This trial is sponsored by The California Medical Innovations Institute, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05412069 being conducted?
This trial has 2 study locations across California, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fecal Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mechanisms of Improving Fecal Continence Muscles Motor Function
RECRUITING · NA
-
Autologous Muscle Fiber Fragment Injections
RECRUITING · NA
-
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
RECRUITING · NA
-
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
RECRUITING · NA
-
Acute Genital Nerve Stimulation for Neurogenic Bowel Dysfunction in Individuals Living With Spinal Cord Injury
RECRUITING · NA
-
Fecal Incontinence Treatment (FIT) Study
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.